MDR1 3435T and 1236T alleles delay disease progression to pediatric AIDS but have no effect on HIV-1 vertical transmission

AIDS
Carolina P BellusciAndrea Mangano

Abstract

Single nucleotide polymorphisms (SNPs) in the MDR1 gene, coding for the drug transporter P-glycoprotein, may modulate the response to antiretroviral therapy and susceptibility to HIV-1 infection. We investigated whether the MDR1 SNPs C1236T (exon 12) and C3435T (exon 26) affect HIV-1 vertical transmission and progression to pediatric AIDS. The MDR1 genotypes were identified by PCR-restriction fragment length polymorphism (RFLP) assays in 219 HIV-infected, 128 exposed uninfected children and 231 HIV-seronegative blood donors. Genotype and haplotype frequencies were estimated in the different groups. The median follow-up time of the infected cohort was 108 months and AIDS-free time was evaluated for the different MDR1 genotypes in 171 HIV-infected children. We found that both C1236T and C3435T polymorphisms were highly frequent in the studied groups (approximately 0.44) and showed strong linkage disequilibrium. There was no association between MDR1 genotypes and HIV-1 vertical transmission. However, a protective effect against progression to AIDS was associated with MDR1 3435CT, 1236CT and 1236TT genotypes (P = 0.005, P = 0.024 and P = 0.026, respectively). Moreover, haplotype pairs' analysis showed that the 3435CT/1236CT and 343...Continue Reading

References

Nov 30, 1992·Biochemical and Biophysical Research Communications·I A de Lannoy, M Silverman
Jul 1, 1986·Somatic Cell and Molecular Genetics·A FojoI Pastan
Jan 1, 1995·Annual Review of Genetics·M M GottesmanI Pastan
Feb 7, 1998·The Journal of Clinical Investigation·R B KimG R Wilkinson
Mar 4, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C G LeeM M Gottesman
Mar 9, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·A ManganoL Sen
Sep 26, 2000·Molecular Genetics and Metabolism·D E Comings, J P MacMurray
Oct 12, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L J Burke, A Baniahmad
Aug 15, 2001·Clinical Pharmacology and Therapeutics·R B KimG R Wilkinson
Feb 28, 2002·The Journal of Infectious Diseases·Eleonora TresoldiUNKNOWN Italian Register for HIV Infection in Children
Jun 29, 2002·Journal of the American Society of Nephrology : JASN·Michael SiegsmundHiltrud Brauch
Aug 21, 2002·Journal of Virology·Manuel LlanoEric M Poeschla
Jan 28, 2003·Therapeutic Drug Monitoring·Maria Luisa BernalEsteban Mayayo
Oct 4, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Todd HulganDavid W Haas
Nov 6, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·David W HaasRichard B Kim
Jan 30, 2004·Clinical Pharmacology and Therapeutics·Catia MarzoliniRichard B Kim
Feb 10, 2004·The Journal of Infectious Diseases·Gabriela BleiberUNKNOWN Swiss HIV Cohort Study
Apr 17, 2004·Journal of Neurochemistry·Patrick T RonaldsonReina Bendayan
Jul 9, 2004·International Journal of Cancer. Journal International Du Cancer·Chuanxi Cai, Jianwen Chen
Mar 9, 2005·British Journal of Clinical Pharmacology·Andrew OwenMunir Pirmohamed
May 25, 2005·Fundamental & Clinical Pharmacology·Andrew OwenDavid J Back
Mar 9, 2007·Retrovirology·Maurizio CianfrigliaLucia Palmisano
Apr 9, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sher L HendricksonStephen J O'Brien
Mar 17, 2009·Biochimica Et Biophysica Acta·King Leung Fung, Michael M Gottesman

❮ Previous
Next ❯

Citations

May 28, 2010·Pharmacogenomics·Ekaitz Errasti-Murugarren, Marçal Pastor-Anglada

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.